Anorectal function and quality of life in patients with early stage rectal cancer treated with chemoradiation and local excision Journal Article


Authors: Lynn, P. B.; Renfro, L. A.; Carrero, X. W.; Shi, Q.; Strombom, P. L.; Chow, O.; Garcia-Aguilar, J.
Article Title: Anorectal function and quality of life in patients with early stage rectal cancer treated with chemoradiation and local excision
Abstract: BACKGROUND: Little is known about anorectal function and quality of life after chemoradiation followed by local excision, which is an alternative to total mesorectal excision for selected patients with early rectal cancer. OBJECTIVE: The purpose of this study was to prospectively assess anorectal function and health-related quality of life of patients with T2N0 rectal cancer who were treated with an alternative approach. DESIGN: This was a prospective, phase II trial. SETTINGS: The study was multicentric (American College of Surgeons Oncology Group trial Z6041). INTERVENTIONS: Patients with stage cT2N0 rectal adenocarcinomas were treated with an oxaliplatin/capecitabine-based chemoradiation regimen followed by local excision. MAIN OUTCOME MEASURES: Anorectal function and quality of life were assessed at enrollment and 1 year postoperatively with the Fecal Incontinence Severity Index, Fecal Incontinence Quality of Life scale, and Functional Assessment of Cancer Therapy-Colorectal Questionnaire. Results were compared, and multivariable analysis was performed to identify predictors of outcome. RESULTS: Seventy-one patients (98%) were evaluated at enrollment and 66 (92%) at 1 year. Compared with baseline, no significant differences were found on Fecal Incontinence Severity Index scores at 1 year. Fecal Incontinence Quality of Life results were significantly worse in the lifestyle (p < 0.001), coping/behavior (p < 0.001), and embarrassment (p = 0.002) domains. There were no differences in the Functional Assessment of Cancer Therapy overall score, but the physical well-being subscale was significantly worse and emotional well-being was improved after surgery. Treatment with the original chemoradiation regimen predicted worse depression/self-perception and embarrassment scores in the Fecal Incontinence Quality of Life, and male sex was predictive of worse scores in the Functional Assessment of Cancer Therapy overall score and trial outcome index. LIMITATIONS: Small sample size, relatively short follow-up, and absence of information before cancer diagnosis were study limitations. CONCLUSIONS: Chemoradiation followed by local excision had minimal impact on anorectal function 1 year after surgery. Overall quality of life remained stable, with mixed effects on different subscales. This information should be used to counsel patients about expected outcomes. © The ASCRS 2016.
Keywords: treatment outcome; aged; middle aged; clinical trial; pathophysiology; neoadjuvant therapy; cancer staging; neoplasm staging; adenocarcinoma; quality of life; phase 2 clinical trial; tumor volume; psychology; pathology; postoperative complications; tumor burden; multicenter study; outcome and process assessment (health care); colon resection; rectal neoplasms; chemoradiation; chemoradiotherapy; rectal cancer; fecal incontinence; adverse effects; colectomy; local excision; procedures; humans; human; male; female; anorectal function
Journal Title: Diseases of the Colon and Rectum
Volume: 60
Issue: 5
ISSN: 0012-3706
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-05-01
Start Page: 459
End Page: 468
Language: English
DOI: 10.1097/dcr.0000000000000758
PUBMED: 28383445
PROVIDER: scopus
PMCID: PMC5384260
DOI/URL:
Notes: Article -- Export Date: 2 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Oliver   Chow
    20 Chow
  2. Patricio Bernardo Lynn
    13 Lynn